Home
About Us
Products
Manus Aktteva Biopharma LLP, an ISO 9001: 2008 certified sourcing & export concern takes pride in fulfilling your requirements of Nutraceuticals, Specialty Chemicals, Pharmaceutical APIs and their advance level intermediates from ISO Certified, GMP, CGMP & USFDA approved units with supportive regulatory documentations like DMF, EDMF, COS, USDMF etc. We wish to state that anyone interested in sourcing any special molecules, APIs, Intermediates, Chiral Compounds etc. and feels it is difficult for early completion of tasks, please call on us and TEST US TO GET THE BEST OF US.
Category
Recommended
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk. Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1)
Enquiry
Quick Links
Blog
Contact Us

Doripenem (CAS No.: 148016-81-3)

Manus Aktteva Biopharma LLP is an ISO 9001:2015 Certified Global Supplier based in India for the product Doripenem, 148016-81-3.
We offer the product Doripenem, 148016-81-3 from our manufacturer / supplier / principals for your Research and Development / Evaluation or Commercial requirements, based on the product's availability from our network. We can also offer Doripenem, 148016-81-3 intermediates with the supportive technical package required for evaluation.
We respect our customer's requirements of strict regulatory compliance and specification needs by offering the API - Active Pharmaceutical Ingredients and intermediates transparently while offering easy access to manufacturer / supplier / principals with affordable and high-quality raw materials.
If you are looking for the API -Active Pharmaceutical Ingredients Doripenem, 148016-81-3 manufacturer supplier who is reliable and meets your required quality standard requirements in the first place, you are at the right place!

CAS number:

148016-81-3

Chemical Name:

(+)-(4R,5S,6S)-6-[(1R)-1-Hydro-xyethyl]-4-methyl-7-oxo-3-[[(3S,5S)-5-[(sulfamoylamino)-methyl]-3-pyrrolidinyl]thio]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, Doripenem (CAS No.: 148016-81-3)

Pharmacopeia:

EP, In House

Manufacturer Certificate:

Factory GMP, cGMP, WHO GMP, ISO Certified

Application:

For R&D Purpose

Properties
Related Intermediates

Synonym

(+)-(4R,5S,6S)-6-[(1R)-1-Hydro-xyethyl]-4-methyl-7-oxo-3-[[(3S,5S)-5-[(sulfamoylamino)-methyl]-3-pyrrolidinyl]thio]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, Doripenem (CAS No.: 148016-81-3)

Molecular Formula

C15H24N4O6S2

Molecular Weight

420.50

Manufacturer Specifications

Available on request

Packing

Export worthy packing

Material Safety Data Sheet

Available on request

Availability

FOR R&D PURPOSE

Product Name	CAS No.
(3S,4R)-4-Acetoxy-3-[(R)-1-(tert-butyldimethylsilyloxy)ethyl]azetidin-2-one	76855-69-1	View \| Inquire
(3S,4S)-3-((R)-(tert-Butyldimethyl-silyloxy)ethyl)-4((R)-carboxyethyl)-2-azetidinone	90776-58-2	View \| Inquire
p-Nitrobenzyl-6-(1-hydroxyethyl)-1-azabicyclo(3.2.0)heptane-3,7-dione-2-carboxylate	74288-40-7	View \| Inquire
beta-Methyl vinyl phosphate (MAP)	90776-59-3	View \| Inquire
4-Nitrobenzyl (2S,4S)-4-acetylthio-2-[[N-sulfamoyl-N-(tert-butoxycarbonyl)amino]methyl]pyrrolidine-1-carboxylate	491878-06-9	View \| Inquire
Doripenem Side Chain intermediate	104773-40-2	View \| Inquire
Doripenem Condensation Compound	491878-07-0	View \| Inquire
N-(tert-Butoxycarbonyl)sulfamide	148017-28-1	View \| Inquire
N-(tert-Butoxycarbonyl)sulfamide	148017-28-1	View \| Inquire

Description:

Doripenem (common name doripenem monohydrate) is an ultra-broad-spectrum injectable antibiotic.

Manufacturer Documentation / Approvals :

DMF (OPEN PART)	TDP

Products protected by valid patents from a manufacturer are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use from a manufacturer in accordance with 35 USC 271 +A13(1)
Products falling in to controlled substance category / list of schedule drugs shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country.
Manus Aktteva Biopharma LLP assumes no responsibility/liability in case of being imparted with goods which infringe intellectual property in any manner whatsoever which includes patent rights of any individual manufacturer. Manus Aktteva makes no representations or warranties of any kind, express or implied, about the originality or reliability with respect to the intellectual property which includes patents of a manufacturer in its products or services for any purpose.
Manus Aktteva Biopharma LLP warns the sellers not to sell any goods which infringe intellectual property in any manner whatsoever which includes patent rights of any individual or a manufacturer.
Manus Aktteva Biopharma LLP warns the buyers not to use/procure any goods from a manufacturer to achieve a product which might be knowingly causing an infringement of intellectual property in any manner whatsoever which includes patent rights of any individual manufacturer.
This website is updated and maintained by Manus Aktteva Biopharma LLP. As a matter of policy, Manus Aktteva Biopharma LLP does not entertain any anonymous or pseudonymous inquiries.

Are you looking for Doripenem (CAS No.: 148016-81-3) with documentation like USDMF, EDMF, CEP / COS, PMDA - JAPAN, DMF - CANADA, TGA - AUSTRALIA, DMF (CLOSED PART), MHRA - UK, DMF - KOREA, AIFA - ITALY, MEDSAFE - NEW ZEALAND, HEALTH CANADA, JDMF, JAPAN - AFM, DMF - CTD, DCGI, ICH, COPP, TDMF, Written Confirmation? Please click here to send us sourcing request.

Why Us